Amnioreduction in Polyhydramnios
- Conditions
- Polyhydramnios
- Registration Number
- NCT07067593
- Lead Sponsor
- Assiut University
- Brief Summary
The aim of this work is to review the indications, procedural complications and outcomes of amnioreduction in pregnancies complicated by polyhydramnios.
- Detailed Description
Polyhydramnios is the presence of excessive amniotic fluid in the amniotic sac and it's prevalence reaches 2% of all pregnancies . Polyhydramnios is diagnosed based on ultrasound criteria, as an amniotic fluid index (AFI) \>25 cm or maximal vertical pocket \> 8 cm . There is a recognized association of polyhydramnios and adverse pregnancy outcomes, including perinatal death, fetal abnormality and preterm birth . Management of the pregnancy can be problematic, particularly in severe cases, due to issues surrounding maternal discomfort and the risk of preterm birth. Amnioreduction, widely used in the management of polyhydramnios, is an option available to palliate maternal symptomatology and potentially prolong the pregnancy . Previous publications have shown a reduction in the risk for premature rupture of membranes and preterm labor decrease, placental perfusion improvement, and relief of maternal discomfort following amnioreduction
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 28
- Pregnant women 20- 38 weeks
- Patients with polyhydramnios
Exclusion criteria:
- Lethal fetal anomalies
- Pre labor rupture of membranes
- Placental separation
- Chorioamnionitis
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gestational age at delivery 4 months Determine Gestational age at delivery in polyhydramnios patients . Increased age is good.
Rate of PROM 4 months Number of cases developed PROM
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Women's Health Hospital
🇪🇬Assiut, Egypt
Women's Health Hospital🇪🇬Assiut, EgyptMohamed FekryContact0882312388mohamedbeethoven2040@gmail.comMohamed Fekry, PhDPrincipal Investigator